Zobrazeno 1 - 10
of 157
pro vyhledávání: '"Shohei Yamashina"'
Autor:
Toshiki Matsui, Shohei Yamashina, Shinro Matsuo, Mark I. Travin, Arnold F. Jacobson, Tomoaki Nakata, Kenichi Nakajima, Takahisa Yamada, Shu Kasama, Mitsuru Momose
Publikováno v:
European Journal of Nuclear Medicine and Molecular Imaging
Purpose Prediction of mortality risk is important in the management of chronic heart failure (CHF). The aim of this study was to create a prediction model for 5-year cardiac death including assessment of cardiac sympathetic innervation using data fro
Autor:
Tomoaki Nakata, Kenichi Nakajima, Takahisa Yamada, Shinro Matsuo, Mark I. Travin, Arnold F. Jacobson, Toshiki Matsui, Shohei Yamashina, Mitsuru Momose, Shu Kasama
Publikováno v:
JACC: Cardiovascular Imaging. 6:772-784
ObjectivesThe study objectives were to create a cardiac metaiodobenzylguanidine (mIBG) database using multiple prospective cohort studies and to determine the quantitative iodine-123–labeled mIBG indices for identifying patients with chronic heart
Autor:
Hitomi Yuzawa, Atsushi Namiki, Hajime Nakano, Shinichiro Fujimoto, Junichi Yamazaki, Shohei Yamashina, Shinji Hisatake, Shuji Nanjo
Publikováno v:
European Journal of Heart Failure. 13:892-898
Aims Loop diuretics are essential for the treatment of chronic heart failure (CHF) but short-acting diuretics are reported to induce sympathetic nervous system (SNS) activation. This study was performed to compare therapeutic effects of two loop diur
Publikováno v:
Annals of Nuclear Medicine. 25:101-107
The goals of this meta-analysis were to determine survival rates in patients with heart failure (HF) assessed by 123I-MIBG imaging results using recently published studies and to determine the prognostic value of 123I-MIBG imaging. We reviewed publis
Autor:
Atsushi Namiki, Yuko Utanohara, Rine Nakanishi, Junichi Yamazaki, Kazuhisa Takamura, Aritomo Inoue, Shinichiro Fujimoto, Shohei Yamashina
Publikováno v:
Nuclear Medicine Communications. 31:488-494
OBJECTIVES Although it has been reported that (123)I-metaiodobenzylguanidine (MIBG) myocardial scintigraphy is useful for assessing the prognosis of dilated cardiomyopathy (DCM), there have been no reports regarding how interval MIBG imaging should b
Autor:
Kenichi Nakajima, Kazuyuki Sakata, Koichi Okuda, Mitsuru Momose, Shinro Matsuo, Shinichiro Kumita, Shohei Yamashina, Jun Hashimoto, Masaya Kawano
Publikováno v:
Annals of Nuclear Medicine. 23:517-522
The standard patterns of myocardial radiotracer distribution of (123)I-metaiodobenzylguanidine (MIBG) and (123)I-beta-methyl-p-iodophenyl-pentadecanoic acid (BMIPP) should be defined in a Japanese population. The purpose of this study was to present
Autor:
Shohei Yamashina, Eiju Uchinuma, Akira Takeda, Yuichi Kadoya, Motoyoshi Nomizu, Ryuji Masuda, Mayumi Mochizuki, Kentaro Hozumi
Publikováno v:
Wound Repair and Regeneration. 17:127-135
Novel peptide-conjugated chitosan membranes were fabricated and used to deliver keratinocytes to dermal wounds in mice. Three active peptides of 12 or 13 amino acids each, RLVSYNGIIFFLK (A5G27), ASKAIQVFLLAG (A5G33), and AGTFALRGDNPQG (A99) were sele
Autor:
Shohei Yamashina, Shuji Nanjo, Hajime Nakano, Junichi Yamazaki, Yasuto Uchida, Kenji Wagatsma, Shinichiro Fujimoto
Publikováno v:
Journal of Cardiology. 51(2):121-130
SummaryBackgroundAlthough there are many reports on Ampulla Cardiomyopathy, its etiologic mechanisms are not well known.AimEtiology of Ampulla Cardiomyopathy was investigated by myocardial scintigraphy with various nuclear tracers.Subjects and method
Autor:
Koichi Yokozuka, Shohei Yamashina, Mitsuru Momose, Masahiro Kubota, Koichi Morita, Shinichiro Kumita, Yoshio Ishida, Junichi Taki, Hirotaka Maruno, Kenichi Nakajima, Masami Ogawa, Jun Hashimoto, Tetsuro Odagawa, Munehiro Takahashi
Publikováno v:
Annals of Nuclear Medicine. 21:505-511
Standards for myocardial single-photon emission computed tomography (SPECT) adapted for a Japanese population were not available. The purpose of this study was to create standard files approved by the Japanese Society of Nuclear Medicine and to make
Publikováno v:
Annals of Nuclear Medicine. 21:399-404
Various clinical trials for dilated cardiomyopathy (DCM) have demonstrated that the prognosis as well as cardiac function is improved by the administration of beta-blocker therapy. On the other hand, 123I-betamethyl-p-iodophenyl-pentadecanoic acid (B